Search

Displaying results 3801 - 3810 of 4860 in total
  1. Drug

    CG7870

    go.drugbank.com/drugs/DB04981
    Investigational

    It is a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer.

  2. Drug

    MLN-977

    go.drugbank.com/drugs/DB05431
    Experimental

    It is developed by PharmaEngine to treat asthma and chronic obstructive pulmonary disease.

  3. Drug

    Tulathromycin A

    go.drugbank.com/drugs/DB11474
    ExperimentalVet approved

    It is marketed by Pfizer Inc. under the tradename Draxxin.

  4. Drug

    CDX-6512

    go.drugbank.com/drugs/DB17841
    Experimental

    Developed by Codexis, it is being investigated for the treatment of homocystinuria And Maple Syrup Urine Disease.[L46651, L46656]

  5. Drug

    Toloxatone

    go.drugbank.com/drugs/DB09245
    Experimental

    It acts as a selective and reversible inhibitor of monoamine oxidase-A (MOA) [L1388].

  6. Drug

    Virginiamycin M1

    go.drugbank.com/drugs/DB01669
    Experimental

    It is produced by Streptomyces graminofaciens and other bacteria.

  7. Drug

    Cycloleucine

    go.drugbank.com/drugs/DB04620
    Experimental

    It is also a specific and reversible inhibitor of nucleic acid methylation and widely used in biochemical experiments.

  8. Drug

    Cyclic adenosine monophosphate

    go.drugbank.com/drugs/DB02527
    Investigational

    Cyclic adenosine monophosphate (cAMP, cyclic AMP or 3'-5'-cyclic adenosine monophosphate) is a molecule that is important in many biological processes; it is derived from adenosine triphosphate (ATP).

  9. Drug

    Pradofloxacin

    go.drugbank.com/drugs/DB11453
    ExperimentalVet approved

    It was approved by the European Commission in April 2011 for bacterial infections in dogs and cats.

  10. Drug

    Talampanel

    go.drugbank.com/drugs/DB04982
    Investigational

    It is a type of AMPA receptor antagonist.